[Stewart-Treves syndrome (angiosarcoma on lyphoedema): A rare complication of lymphoedema].
Identifieur interne : 002866 ( PubMed/Curation ); précédent : 002865; suivant : 002867[Stewart-Treves syndrome (angiosarcoma on lyphoedema): A rare complication of lymphoedema].
Auteurs : Eva Wierzbicka-Hainaut [France] ; Gérard GuilletSource :
- Presse medicale (Paris, France : 1983) [ 2213-0276 ] ; 2010.
Descripteurs français
- KwdFr :
- Association thérapeutique, Complications postopératoires (diagnostic), Complications postopératoires (mortalité), Complications postopératoires (étiologie), Femelle, Humains, Hémangiosarcome (), Hémangiosarcome (diagnostic), Hémangiosarcome (mortalité), Hémangiosarcome (étiologie), Lymphangiosarcome (), Lymphangiosarcome (diagnostic), Lymphangiosarcome (mortalité), Lymphangiosarcome (étiologie), Lymphoedème (), Lymphoedème (diagnostic), Lymphoedème (mortalité), Maladie chronique, Mastectomie radicale, Pronostic, Taux de survie, Tumeurs du sein (), Tumeurs du sein (mortalité).
- MESH :
- diagnostic : Complications postopératoires, Hémangiosarcome, Lymphangiosarcome, Lymphoedème.
- mortalité : Complications postopératoires, Hémangiosarcome, Lymphangiosarcome, Lymphoedème, Tumeurs du sein.
- étiologie : Complications postopératoires, Hémangiosarcome, Lymphangiosarcome.
- Association thérapeutique, Femelle, Humains, Hémangiosarcome, Lymphangiosarcome, Lymphoedème, Maladie chronique, Mastectomie radicale, Pronostic, Taux de survie, Tumeurs du sein.
English descriptors
- KwdEn :
- Breast Neoplasms (mortality), Breast Neoplasms (surgery), Chronic Disease, Combined Modality Therapy, Female, Hemangiosarcoma (diagnosis), Hemangiosarcoma (etiology), Hemangiosarcoma (mortality), Hemangiosarcoma (therapy), Humans, Lymphangiosarcoma (diagnosis), Lymphangiosarcoma (etiology), Lymphangiosarcoma (mortality), Lymphangiosarcoma (therapy), Lymphedema (complications), Lymphedema (diagnosis), Lymphedema (mortality), Mastectomy, Radical, Postoperative Complications (diagnosis), Postoperative Complications (etiology), Postoperative Complications (mortality), Prognosis, Survival Rate.
- MESH :
- complications : Lymphedema.
- diagnosis : Hemangiosarcoma, Lymphangiosarcoma, Lymphedema, Postoperative Complications.
- etiology : Hemangiosarcoma, Lymphangiosarcoma, Postoperative Complications.
- mortality : Breast Neoplasms, Hemangiosarcoma, Lymphangiosarcoma, Lymphedema, Postoperative Complications.
- surgery : Breast Neoplasms.
- therapy : Hemangiosarcoma, Lymphangiosarcoma.
- Chronic Disease, Combined Modality Therapy, Female, Humans, Mastectomy, Radical, Prognosis, Survival Rate.
Abstract
Stewart-Treves syndrome (SST) or former lymphangiosarcoma is a rare complication of chronic lymphoedema mainly related to the breast cancer (90% of cases). It occurs in 0.03% of patients surviving 10 or more years after radical mastectomy. The prognosis is very poor with a five-year survival close to 10% despite the various treatment modalities. The treatment of choice is a large resection, but some authors recommend radical resection in the form of shoulder disarticulation or forequarter amputation. Surgical treatment can be preceded or followed by radiation therapy. Locally advanced tumors or metastatic forms can be treated with mono or polychemotherapy, systemic or local.
DOI: 10.1016/j.lpm.2010.06.017
PubMed: 20970956
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: Pour aller vers cette notice dans l'étape Curation :002866
Links to Exploration step
pubmed:20970956Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">[Stewart-Treves syndrome (angiosarcoma on lyphoedema): A rare complication of lymphoedema].</title>
<author><name sortKey="Wierzbicka Hainaut, Eva" sort="Wierzbicka Hainaut, Eva" uniqKey="Wierzbicka Hainaut E" first="Eva" last="Wierzbicka-Hainaut">Eva Wierzbicka-Hainaut</name>
<affiliation wicri:level="1"><nlm:affiliation>CHU de Poitiers, service de dermatologie, 86021 Poitiers cedex, France. e.wierzbicka@chu-poitiers.fr</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>CHU de Poitiers, service de dermatologie, 86021 Poitiers cedex</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Guillet, Gerard" sort="Guillet, Gerard" uniqKey="Guillet G" first="Gérard" last="Guillet">Gérard Guillet</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2010">2010</date>
<idno type="RBID">pubmed:20970956</idno>
<idno type="pmid">20970956</idno>
<idno type="doi">10.1016/j.lpm.2010.06.017</idno>
<idno type="wicri:Area/PubMed/Corpus">002866</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">002866</idno>
<idno type="wicri:Area/PubMed/Curation">002866</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">002866</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">[Stewart-Treves syndrome (angiosarcoma on lyphoedema): A rare complication of lymphoedema].</title>
<author><name sortKey="Wierzbicka Hainaut, Eva" sort="Wierzbicka Hainaut, Eva" uniqKey="Wierzbicka Hainaut E" first="Eva" last="Wierzbicka-Hainaut">Eva Wierzbicka-Hainaut</name>
<affiliation wicri:level="1"><nlm:affiliation>CHU de Poitiers, service de dermatologie, 86021 Poitiers cedex, France. e.wierzbicka@chu-poitiers.fr</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>CHU de Poitiers, service de dermatologie, 86021 Poitiers cedex</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Guillet, Gerard" sort="Guillet, Gerard" uniqKey="Guillet G" first="Gérard" last="Guillet">Gérard Guillet</name>
</author>
</analytic>
<series><title level="j">Presse medicale (Paris, France : 1983)</title>
<idno type="eISSN">2213-0276</idno>
<imprint><date when="2010" type="published">2010</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Breast Neoplasms (mortality)</term>
<term>Breast Neoplasms (surgery)</term>
<term>Chronic Disease</term>
<term>Combined Modality Therapy</term>
<term>Female</term>
<term>Hemangiosarcoma (diagnosis)</term>
<term>Hemangiosarcoma (etiology)</term>
<term>Hemangiosarcoma (mortality)</term>
<term>Hemangiosarcoma (therapy)</term>
<term>Humans</term>
<term>Lymphangiosarcoma (diagnosis)</term>
<term>Lymphangiosarcoma (etiology)</term>
<term>Lymphangiosarcoma (mortality)</term>
<term>Lymphangiosarcoma (therapy)</term>
<term>Lymphedema (complications)</term>
<term>Lymphedema (diagnosis)</term>
<term>Lymphedema (mortality)</term>
<term>Mastectomy, Radical</term>
<term>Postoperative Complications (diagnosis)</term>
<term>Postoperative Complications (etiology)</term>
<term>Postoperative Complications (mortality)</term>
<term>Prognosis</term>
<term>Survival Rate</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr"><term>Association thérapeutique</term>
<term>Complications postopératoires (diagnostic)</term>
<term>Complications postopératoires (mortalité)</term>
<term>Complications postopératoires (étiologie)</term>
<term>Femelle</term>
<term>Humains</term>
<term>Hémangiosarcome ()</term>
<term>Hémangiosarcome (diagnostic)</term>
<term>Hémangiosarcome (mortalité)</term>
<term>Hémangiosarcome (étiologie)</term>
<term>Lymphangiosarcome ()</term>
<term>Lymphangiosarcome (diagnostic)</term>
<term>Lymphangiosarcome (mortalité)</term>
<term>Lymphangiosarcome (étiologie)</term>
<term>Lymphoedème ()</term>
<term>Lymphoedème (diagnostic)</term>
<term>Lymphoedème (mortalité)</term>
<term>Maladie chronique</term>
<term>Mastectomie radicale</term>
<term>Pronostic</term>
<term>Taux de survie</term>
<term>Tumeurs du sein ()</term>
<term>Tumeurs du sein (mortalité)</term>
</keywords>
<keywords scheme="MESH" qualifier="complications" xml:lang="en"><term>Lymphedema</term>
</keywords>
<keywords scheme="MESH" qualifier="diagnosis" xml:lang="en"><term>Hemangiosarcoma</term>
<term>Lymphangiosarcoma</term>
<term>Lymphedema</term>
<term>Postoperative Complications</term>
</keywords>
<keywords scheme="MESH" qualifier="diagnostic" xml:lang="fr"><term>Complications postopératoires</term>
<term>Hémangiosarcome</term>
<term>Lymphangiosarcome</term>
<term>Lymphoedème</term>
</keywords>
<keywords scheme="MESH" qualifier="etiology" xml:lang="en"><term>Hemangiosarcoma</term>
<term>Lymphangiosarcoma</term>
<term>Postoperative Complications</term>
</keywords>
<keywords scheme="MESH" qualifier="mortality" xml:lang="en"><term>Breast Neoplasms</term>
<term>Hemangiosarcoma</term>
<term>Lymphangiosarcoma</term>
<term>Lymphedema</term>
<term>Postoperative Complications</term>
</keywords>
<keywords scheme="MESH" qualifier="mortalité" xml:lang="fr"><term>Complications postopératoires</term>
<term>Hémangiosarcome</term>
<term>Lymphangiosarcome</term>
<term>Lymphoedème</term>
<term>Tumeurs du sein</term>
</keywords>
<keywords scheme="MESH" qualifier="surgery" xml:lang="en"><term>Breast Neoplasms</term>
</keywords>
<keywords scheme="MESH" qualifier="therapy" xml:lang="en"><term>Hemangiosarcoma</term>
<term>Lymphangiosarcoma</term>
</keywords>
<keywords scheme="MESH" qualifier="étiologie" xml:lang="fr"><term>Complications postopératoires</term>
<term>Hémangiosarcome</term>
<term>Lymphangiosarcome</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Chronic Disease</term>
<term>Combined Modality Therapy</term>
<term>Female</term>
<term>Humans</term>
<term>Mastectomy, Radical</term>
<term>Prognosis</term>
<term>Survival Rate</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr"><term>Association thérapeutique</term>
<term>Femelle</term>
<term>Humains</term>
<term>Hémangiosarcome</term>
<term>Lymphangiosarcome</term>
<term>Lymphoedème</term>
<term>Maladie chronique</term>
<term>Mastectomie radicale</term>
<term>Pronostic</term>
<term>Taux de survie</term>
<term>Tumeurs du sein</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">Stewart-Treves syndrome (SST) or former lymphangiosarcoma is a rare complication of chronic lymphoedema mainly related to the breast cancer (90% of cases). It occurs in 0.03% of patients surviving 10 or more years after radical mastectomy. The prognosis is very poor with a five-year survival close to 10% despite the various treatment modalities. The treatment of choice is a large resection, but some authors recommend radical resection in the form of shoulder disarticulation or forequarter amputation. Surgical treatment can be preceded or followed by radiation therapy. Locally advanced tumors or metastatic forms can be treated with mono or polychemotherapy, systemic or local.</div>
</front>
</TEI>
<pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">20970956</PMID>
<DateCreated><Year>2010</Year>
<Month>12</Month>
<Day>06</Day>
</DateCreated>
<DateCompleted><Year>2011</Year>
<Month>01</Month>
<Day>04</Day>
</DateCompleted>
<DateRevised><Year>2016</Year>
<Month>12</Month>
<Day>09</Day>
</DateRevised>
<Article PubModel="Print"><Journal><ISSN IssnType="Electronic">2213-0276</ISSN>
<JournalIssue CitedMedium="Internet"><Volume>39</Volume>
<Issue>12</Issue>
<PubDate><Year>2010</Year>
<Month>Dec</Month>
</PubDate>
</JournalIssue>
<Title>Presse medicale (Paris, France : 1983)</Title>
<ISOAbbreviation>Presse Med</ISOAbbreviation>
</Journal>
<ArticleTitle>[Stewart-Treves syndrome (angiosarcoma on lyphoedema): A rare complication of lymphoedema].</ArticleTitle>
<Pagination><MedlinePgn>1305-8</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.lpm.2010.06.017</ELocationID>
<Abstract><AbstractText>Stewart-Treves syndrome (SST) or former lymphangiosarcoma is a rare complication of chronic lymphoedema mainly related to the breast cancer (90% of cases). It occurs in 0.03% of patients surviving 10 or more years after radical mastectomy. The prognosis is very poor with a five-year survival close to 10% despite the various treatment modalities. The treatment of choice is a large resection, but some authors recommend radical resection in the form of shoulder disarticulation or forequarter amputation. Surgical treatment can be preceded or followed by radiation therapy. Locally advanced tumors or metastatic forms can be treated with mono or polychemotherapy, systemic or local.</AbstractText>
<CopyrightInformation>Copyright © 2010 Elsevier Masson SAS. All rights reserved.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Wierzbicka-Hainaut</LastName>
<ForeName>Eva</ForeName>
<Initials>E</Initials>
<AffiliationInfo><Affiliation>CHU de Poitiers, service de dermatologie, 86021 Poitiers cedex, France. e.wierzbicka@chu-poitiers.fr</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Guillet</LastName>
<ForeName>Gérard</ForeName>
<Initials>G</Initials>
</Author>
</AuthorList>
<Language>fre</Language>
<PublicationTypeList><PublicationType UI="D004740">English Abstract</PublicationType>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D016454">Review</PublicationType>
</PublicationTypeList>
<VernacularTitle>Syndrome de Stewart-Treves (angiosarcome sur lymphœdème) : complication rare du lymphœdème.</VernacularTitle>
</Article>
<MedlineJournalInfo><Country>France</Country>
<MedlineTA>Presse Med</MedlineTA>
<NlmUniqueID>8302490</NlmUniqueID>
<ISSNLinking>0755-4982</ISSNLinking>
</MedlineJournalInfo>
<SupplMeshList><SupplMeshName Type="Disease" UI="C537491">Stewart Treves syndrome</SupplMeshName>
</SupplMeshList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList><MeshHeading><DescriptorName UI="D001943" MajorTopicYN="N">Breast Neoplasms</DescriptorName>
<QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName>
<QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D002908" MajorTopicYN="N">Chronic Disease</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D003131" MajorTopicYN="N">Combined Modality Therapy</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D006394" MajorTopicYN="N">Hemangiosarcoma</DescriptorName>
<QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName>
<QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName>
<QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName>
<QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D008204" MajorTopicYN="N">Lymphangiosarcoma</DescriptorName>
<QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName>
<QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName>
<QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName>
<QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D008209" MajorTopicYN="N">Lymphedema</DescriptorName>
<QualifierName UI="Q000150" MajorTopicYN="Y">complications</QualifierName>
<QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName>
<QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D015409" MajorTopicYN="N">Mastectomy, Radical</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName>
<QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName>
<QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName>
<QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D011379" MajorTopicYN="N">Prognosis</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D015996" MajorTopicYN="N">Survival Rate</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<PubmedData><History><PubMedPubDate PubStatus="received"><Year>2010</Year>
<Month>03</Month>
<Day>12</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="accepted"><Year>2010</Year>
<Month>06</Month>
<Day>01</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez"><Year>2010</Year>
<Month>10</Month>
<Day>26</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed"><Year>2010</Year>
<Month>10</Month>
<Day>26</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline"><Year>2011</Year>
<Month>1</Month>
<Day>5</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList><ArticleId IdType="pubmed">20970956</ArticleId>
<ArticleId IdType="pii">S0755-4982(10)00527-0</ArticleId>
<ArticleId IdType="doi">10.1016/j.lpm.2010.06.017</ArticleId>
</ArticleIdList>
</PubmedData>
</pubmed>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/PubMed/Curation
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 002866 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd -nk 002866 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Wicri/Sante |area= LymphedemaV1 |flux= PubMed |étape= Curation |type= RBID |clé= pubmed:20970956 |texte= [Stewart-Treves syndrome (angiosarcoma on lyphoedema): A rare complication of lymphoedema]. }}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Curation/RBID.i -Sk "pubmed:20970956" \ | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd \ | NlmPubMed2Wicri -a LymphedemaV1
![]() | This area was generated with Dilib version V0.6.31. | ![]() |